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In  addition  to  endocytosis-mediated  cellular  uptake,  hydrophilic  cell-penetrating  peptides   
are  able  to  traverse  biological  membranes  in  a  non-endocytic  mode  termed  transduction, 
resulting  in  immediate  bioavailability.  Here  we  analysed  structural  requirements  for  the   
non-endocytic  uptake  mode  of  arginine-rich  cell-penetrating  peptides,  by  a  combination 
of  live-cell  microscopy,  molecular  dynamics  simulations  and  analytical  ultracentrifugation.   
We  demonstrate  that  the  transduction  efficiency  of  arginine-rich  peptides  increases  with   
higher peptide structural rigidity. Consequently, cyclic arginine-rich cell-penetrating peptides   
showed enhanced cellular uptake kinetics relative to their linear and more flexible counter-
part. We propose that guanidinium groups are forced into maximally distant positions by   
cyclization.  This  orientation  increases  membrane  contacts  leading  to  enhanced  cell 
penetration. 
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B
eginning  with  the  observation  in  1988  that  the  protein   
HIV-1 TAT crossed membranes of living cells and altered 
gene expression1,2, a variety of so-called protein transduction 
domains  (PTDs)  or  cell-penetrating  peptides  (CPPs)  have  been 
identified and used to introduce attached cargoes into living cells, 
organs or animals. For CPPs containing a low number of arginines3 
or carrying large globular cargoes4, the mode of cellular uptake is 
restricted to endocytosis. The well-studied CPPs TAT and artificial 
oligoarginines belong to the class of arginine-rich CPPs (RRPs). 
These have, in addition, the option to enter the cell in a non-endo-
cytic mode (hereafter referred to as transduction) with immediate 
intracellular bioavailability5,6, if a certain peptide-specific RRP con-
centration threshold is exceeded. These concentration thresholds 
depend on the type of RRP as well as on external factors such as the 
cell line and the extracellular media. Below these concentrations, 
the main route of RRPs cellular entry seems to be endocytosis. In 
contrast to pinocytic or endocytic uptake, transduction of RRPs 
into living cells cannot be prevented by a temperature shift to 4°C 
(refs 5,7). Molecular dynamics simulations with TAT solvated in 
water close to a dioleoloyl phosphatidylcholine lipid bilayer mem-
brane suggested that high concentrations of TAT-peptide can lead 
to membrane thinning, permitting interactions of arginines with 
phosphate groups on the opposite leaflet. This event caused the 
nucleation of a transient, water-filled pore of a size of 3 nm. TAT-
molecules diffused along the surface of these pores to the other side 
of the artificial bilayer8. The formation of transient pores on phos-
pholipid bilayers and on cells was later confirmed experimentally9. 
Transient pore formation of TAT is not supported by permanent 
membrane damage or viability assays in living cells at concentra-
tions slightly above the transduction threshold. This may be attri-
buted to a cellular response towards the peptide incubation, and   
the ultrashort pore formation may be masked by the activity of a 
cellular  membrane  repair  response  mechanism10.  RRPs  facilitate   
the delivery of low molecular weight cargoes (for example, peptides 
up to 30 amino acids, drugs and fluorophores) via the mechanism   
of transduction and are thus appealing tools to modulate protein 
function in living cells11. Nonetheless, it is still poorly understood 
which characteristics apart from their arginine content facilitate 
RRPs to transduce efficiently over the plasma membrane.
In  this  study,  we  combined  live-cell  confocal  microscopy   
analysis  of  cellular  uptake  of  fluorescently  labelled  peptides, 
analytical  ultracentrifugation  and  molecular  dynamics  simu-
lations to define sequence and structural requirements for trans-
duction.  In  this  way,  we  found  that  maximal  separation  of  the   
guanidium  groups  by  cyclization  of  RRPs  enhances  their  non- 
endocytic cellular uptake. We propose that this is due to increased 
membrane  contacts  facilitated  by  the  rigid  cyclic  backbone   
structure.
Results
Arginine-rich CPPs rapidly cross plasma membranes. To deter-
mine the influence of the overall peptide electric charge, the trans-
duction  efficiencies  of  ten  different  peptides  (CPPs,  CPP  with 
cargoes and cargoes alone, Supplementary Fig. S1; Supplementary   
Table S1) were evaluated in a live cell fluorescent transduction assay. 
To  strictly  score  transduced  peptides  and  exclude  endocytosed 
peptides, we analysed the CPPs located in the nucleus. From the 
panel of CPPs, the well-studied RRPs TAT12,13 and the deca-arginine 
(R10) peptide14,15 yielded efficiencies of 97% and 98%, respectively. 
In stark contrast, the CPP PTD4 (ref. 16) could only be found freely 
diffusing inside cells at a percentage of 0.5% (Fig. 1a). All cargoes 
tested were incapable per se to transduce, although the content of 
positively  charged  residues  within  the  sequence  increased  from 
Nemo-binding  domain17  without  positive  charges  (c)  over  the   
VLC-1 peptide containing four lysines (VLC-1)18 (b) to p21 consisting 
of two lysines and five arginines (p21 peptide)4 (a) (Supplementary 
Fig. S1). On fusion to the RRP TAT all fusion peptides were able 
to cross the plasma membrane of living cells in the same manner 
as TAT alone, albeit with lower transduction frequencies (76–85%), 
which might reflect the size of the attached cargo or the presence   
of acidic amino acids within the cargo (Supplementary Fig. S1).
Arginine-rich  CPPs  exist  as  extended  and  rigid  structures.   
A number of studies showed that a minimal number of arginines is   
required  for  transduction6,14,19,20.  Here  we  further  asked  whether 
structural features could explain the high transduction efficiencies   
of TAT and R10. All peptides from the transduction assay (Fig. 1a; 
Supplementary Fig. S1; Supplementary Table S1) were subjected to 
a sedimentation velocity analytical ultracentrifugation experiment. 
TAT linked to the fluorophores FITC (fluorescein isothiocyanate), 
fluorescein and TAMRA (5,6-tetramethyl rhodamine) showed no 
different intracellular distribution and uptake frequency for either 
variant (Supplementary Fig. S2), thus ensuring their eligibility for 
the  sedimentation  velocity  ultracentrifugation  experiments.  The 
frictional ratio f/f0 determined by this analysis allowed the esti-
mation of the gross conformation and dimensions of the peptides   
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Figure 1 | Live-cell transduction ability of CPPs and experimental and 
theoretical shape parameters. (a) The CPPs PTD4, TAT, R10 and cyclic 
TAT were transduced, or otherwise internalized, into living mouse myoblast 
cells in the presence of PBs. Representative transmission images of the 
phase contrast and confocal optical sections of the fluorescent peptides 
are shown. scalebars, 10 µm. Arrows indicate the presence of fluorescent 
peptide inside nucleoli and percentages of the number of transduced cells 
are given. (b) Results from the sedimentation velocity ultracentrifugation 
experiments and subsequent analysis: f/f0: frictional ratio (squares), 
d: diameter, end–end distances (circles). (c) Results of the molecular 
dynamics simulations: radius of gyration (squares) and end–end distances 
(circles). Q* results from a decondensation reaction between a glutamic 
acid and a lysine during cyclization (see supplementary Table 1).ARTICLE     
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(Fig. 1b; Supplementary Table S2). Frictional ratios around 1 imply   
sphere-like particles and, with increasing values, the macromole-
cules can be modelled to more extended and rigid structures. Inter-
estingly, all TAT-containing peptides and R10 exhibited a f/f0 from 
1.29–1.55 ± 0.14 and thus appeared to be extended, whereas the f/f0 
for the non-transducing peptides (without TAT) varied between 
1.00–1.16 ± 0.16 hinting towards a more globular shape (Fig. 1b; 
Supplementary Fig. S1; Supplementary Table S2). To test whether 
elongated structure is correlated with positive charge, the f/f0 was 
plotted as a function of the charge as well as the number of arginines 
(Supplementary Fig. S3), showing in fact, an approximately linear 
correlation between f/f0 and the number of basic residues. Remark-
ably, there is among the peptides tested a step-like switch from no 
transduction to full transduction as the number of basic residues 
reaches  eight  including  six  arginines  (Supplementary  Fig.  S3)6. 
Although the number of charges seems to be important for trans-
duction, it could not be ruled out that the stretched conformation 
may also have a role. The fact that the p21 peptide exhibits a f/f0  
of  1.40  and  thus  has  an  elongated  shape  as  the  transducing   
peptides, but is not able to transduce into living cells (Supplementary   
Fig. S1a), indicates that the extended conformation is not sufficient 
for transduction.
Extended  conformation  is  not  essential  for  transduction.  To 
test  whether  the  stretched  conformation  is  a  necessary  struc-
tural property of RRPs, we cyclized the TAT peptide. Analysing 
the panel of CPPs, implies that, with an increasing number of 
arginines, the length as well as the frictional ratio increases. There 
is a sharp drop in both values for the sterically fixed cyclic form 
of TAT (Fig. 1b). To further characterize structural features for 
the panel of CPPs, probability densities of radius of gyration and   
end-to-end distances were calculated from molecular dynamics 
trajectories (Fig. 1c). In general, the mean conformational exten-
sion increased with the number of arginines, except for the cyclic, 
sterically  constrained  TAT  peptide,  which  exhibited  a  reduced 
radius  of  gyration,  comparable  to  the  more  globular  PTD4.  A 
comparison  between  experimentally  and  theoretically  obtained 
data,  revealed  the  same  distribution  of  values  in  the  graphical 
space, indicating that experimental and theoretical data were in 
reasonable agreement (Fig. 1b,c). Although, the cyclic TAT has a   
significantly  less  stretched  conformation  than  the  other  CPPs 
studied, it unexpectedly transduces with frequencies comparable 
to the other RRPs (Fig. 1a). This indicates that extended conforma-
tion is neither sufficient nor required for the transduction mode   
of cellular uptake of CPPs.
Cyclic TAT transduces with higher efficiency than linear TAT. 
Surprisingly, the cyclic form of TAT was not only able to translo-
cate into living cells with comparable frequencies as the linear TAT   
but  even  exhibited  enhanced  transduction  kinetics  (Fig.  2a,b;   
Supplementary  Movie  1).  Although  both  forms  were  identically 
charged,  the  cyclic  TAT  variant  entered  living  cells  on  average   
15 min  earlier  than  the  linear  form  and  accumulated  to  higher   
levels inside the cells (cyclic: 42.0 ± 8.4 min, linear: 69.6 ± 7.1 min).
Guanidinium groups are more distant in cyclic TAT. As arginines 
seem to be the critical ingredient for CPP uptake, we analysed the 
conformational  dynamics  of  the  arginine  residues.  In  Figure  2c  
(Supplementary Movies 2–5), it can be seen that although the cyclic 
peptide has an overall more compact structure, the arginines are 
more  distant  than  in  the  linear  TAT.  As  both  peptides  harbour 
eight positive charges, the kinetic uptake difference can be attri-
buted to the loss in degrees of freedom in case of the cyclic version, 
which results in a more rigid presentation of arginine side chains   
compared  with  the  quite  flexible  linear  variant  (Supplementary 
Movies 3 and 5). As a consequence, the average distance between 
the guanidinium groups calculated for the cyclic TAT is longer than 
the one calculated for the other RRPs (Fig. 2c), indicating that this   
is an important parameter for the kinetics of transduction.
Larger guanidinium group separation enhances uptake kinetics. 
It has been shown that by increasing the distance between arginine 
amino  acids  enhances  the  uptake  of  RRPs25.  This  was  done  by 
introducing spacers such as glycine amino acids between arginine 
amino acids. Now, by cyclizing the TAT peptide, we can see that it 
is possible to increase the distance between the guanidinium groups 
without performing any mutations of the peptide. If the separation 
of the guanidium groups is indeed a critical factor for this uptake 
kinetic difference, then it is expected that this difference should 
be much pronounced in a peptide composed entirely of arginines. 
In this case, there is a higher number of guanidinium groups and 
the arginines are not separated by any other amino acids as in the 
case of the TAT peptide. To corroborate this kinetical difference, 
the uptake of cyclic and linear R10 was analysed with the live cell 
microscopic  fluorescence  assay.  Cyclic  R10  transduced  several-
fold stronger than linear R10, indicated by quicker intranucleolar   
occurrence and higher intensities over time (Fig. 3).
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Figure 2 | Kinetic uptake characteristics of a linear and cyclic form  
of TAT. (a) Confocal optical sections of timelapse movies (supplementary 
movie 1) show the uptake of fluorescently labelled linear and cyclic 
TAT in the presence of serum-free medium. scalebar, 10 µm. (b) mean 
fluorescence intensity of fluorescein-labelled linear (triangles) and cyclic 
(circles) TAT inside the nucleus was monitored over 60 min at a frame rate 
of one image every 79 s. (c) Radii of gyration (circles) and guanidinium 
group distances (squares) derived from the molecular dynamics 
simulations.ARTICLE
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As  predicted,  the  difference  in  uptake  amount  and  kinetics   
between  linear  and  cyclic  R10  are  far  more  pronounced  than 
between the TAT counterparts (Figures 2 and 3).
Discussion
We and others have previously reported a concentration-depend-
ent threshold for transduction4,21 and an enrichment of RRPs on 
the membrane surface22–24. On docking to the phospholipids of the 
plasma membrane, the stabilized outwards presentation of arginines 
in cyclic TAT might facilitate the formation of RRP assemblies on 
the cell membranes, initiating transduction earlier than in the case 
of its linear counterpart. Alternatively, the larger distance between 
arginines in cyclic TAT may lower the entropic barrier for structures 
that reach across the membrane, bridging the distance between the 
polar regions on either side of the lipid bilayer8.
In linear peptides, it has been observed25 that enhancing the 
spacing between arginine residues increases the uptake of RRP sug-
gesting that the spacing between arginine residues is important for 
uptake. By cyclization of the peptides, as done here, we show that 
the distance between the guanidinium groups can also be increased 
without  introducing  any  mutation  in  the  sequence.  This  also   
leads to a significant enhancement in the uptake of the TAT peptide   
narrowing the critical structural aspect to the separation between   
the guanidium groups. Consequently, this effect is more pronounced 
in  the  cyclic  R10  peptide  that  is  entirely  composed  of  arginine   
amino acids.
In  summary,  we  show  here  that  the  non-endocytic  mode  of 
entry by RRPs, termed transduction, depends solely on the number 
of arginines, and the transduction kinetics of an RRP with a given 
number of arginines can be enhanced by positional fixation of its 
guanidinium groups, for example, via backbone cyclization. This 
restriction in the conformational degrees of freedom can be com-
pared with a state of a statistically reduced number of conformers. 
This could be achieved also by temperature reduction. Indeed, it   
has been described that transduction of the linear RRP R9 occurred 
earlier with decreasing temperature in living cells7. Therefore, we 
propose  that  a  less  flexible  presentation  of  arginine  side  chains   
distributed over the peptide surface within the cyclic TAT, together 
with its disc-like appearance, leads to a quicker and more dense 
occupation  of  the  plasma  membrane  and  thus  results  in  faster 
transduction kinetics. These features might facilitate the docking 
process  to  negatively  charged  membrane  constituents.  Consist-
ently, a higher transduction potential of guanidinium groups on   
a  glycoside  core  that  resulted  in  a  semi-rigid  conformation  has   
been reported26. Altogether, our data suggest that rigidity resulting 
in an ideal interface for interaction with membrane constituents is 
more important than structural flexibility27 to facilitate transduction. 
We directly show that ‘needle’-like structures are not required for 
transduction  and  increased  distances  between  the  guanidinium 
groups  and  structural  rigidity  kinetically  enhances  transduction 
efficiency of arginine-rich CPPs. These findings suggest alternative 
engineering strategies of novel and more efficient vectors to trans-
port compounds into living cells and organisms.
Methods
Cells. C2C12 mouse myoblasts were seeded at 70% confluency into 8-well micro-
scope observation chambers (ibidi) and the growth medium (Dulbecco’s modified 
Eagle medium; PAA) supplemented with 20% fetal calf serum (Life Technologies) 
and gentamycin was exchanged against the peptide solutions.
Peptides. The peptides (Supplementary Table S1) were synthesized using standard 
Fmoc- and Fboc-chemistry (Peptide Specialty Laboratories BioTez). The cycliza-
tion of the cTAT and cR10 peptide was realized between an extra lysine and 
glutamic acid, which resulted in a TAT-ring with the same overall charge as in the 
native linear form.
Transduction experiments. Peptides were diluted to 15 µM final concentration 
in 200 µl phosphate buffered saline, pH 7.4 (PBS) and incubated with the cells for 
60 min at 37°C. Subsequently, the peptide solution was gently exchanged against 
growth medium.
For the timelapses (Supplementary Movies 1 and 6), cells were treated as 
described above, with the exception that the peptides were diluted in growth medium 
without fetal calf serum to a final concentration of 20 µM. The UV/VIS absorption 
spectra for cyclic and linear variants indicated identical peptide concentrations and 
fluorescent labelling (shown for the linear and cyclic TAT in Supplementary Fig. S4a).
Confocal microscopy and image analysis. Confocal microscopy images were 
acquired with a LSM510 Meta system mounted on an Axiovert 200 M inverted 
microscope and using a 63x phase contrast planapochromat oil objective NA1.4 
(Zeiss). The microscope was equipped with a live-cell incubation chamber main-
taining a humidified atmosphere of 5% CO2 and 37°C (Okolab). For all settings, 
the main beam splitter was HFT UV/488/543/633, and the specific parameters for 
the single fluorophores were as follows: TAMRA (R) labelled peptides were excited 
at 543 nm, detected with a 565–615 nm band-pass filter and FITC (F) or fluorescein 
(Fl) labelled peptides were excited at 488 nm and detected with a 500–530 nm 
band-pass filter. Phase contrast images were recorded with excitation at 488 nm 
and detection in the transmission channel. Laser power for observation was 1% at 
488 nm, 25 mW and 50% at 543 nm, 1 mW.
Settings were adjusted in a way that image pixels were not over or under-
exposed with the range indicator function in the Zeiss LSM software version 3.2. 
The macro ‘Multi Time Series Rev. 3.2m (ref. 28) (Zeiss) was used to record in 
parallel the uptake of the linear and cyclic variants of TAT in two different wells of 
the observation chambers. This methodology guaranteed an identical peptide to 
cell ratio for the measurement, which is crucial for transduction experiments.
The uptake movies were generated with the macro ‘Concatenate Macro for 
LSM 3.2 (ref. 28) (Supplementary Movies 1 and 6). For the uptake analysis, all 
extranuclear fluorescence was masked and the increase in fluorescence intensity 
after peptide application was graphed as average intensity inside whole nuclei.  
To further correct for small differences, which may arise from heterogeneity  
of the sample chambers at distinct locations, the histograms taken from the  
extracellular fluorescence in the movies were compared and the curves obtained 
for intranuclear fluorescence intensity increase were corrected for this minor  
differences (Supplementary Fig. S4b). Furthermore, the graphs were bleach  
corrected by choosing extracellular ROIs of 80 x 80 pixels for both peptides.
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Figure 3 | Kinetic uptake characteristics of a linear and cyclic form  
of R10. (a) Confocal optical sections of timelapse movies (supplementary 
movie 6) show the uptake of fluorescently labelled linear and cyclic R10  
in the presence of serum-free medium. scalebar, 10 µm. Because of the 
much higher cellular uptake of these peptides, the contrast adjustment 
needed does not allow visualization of the peptide in the extracellular 
media as in the TAT case (Fig. 2a). (b) mean fluorescence intensity of 
fluorescein-labelled linear (triangles) and cyclic (circles) R10 inside  
the nucleus was monitored over 60 min at a frame rate of one image  
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Sedimentation velocity ultracentrifugation analysis. The shape parameters  
of the peptides listed in the Supplementary Table S2 were determined by  
analytical ultracentrifugation. Molecular mass studies were carried out using  
an analytical ultracentrifuge XL-A (Beckmann). Minimally 400 µl of the peptides 
dissolved in 4 mM phosphate buffer, pH 7.45, containing 0.3 M NaCl were centri-
fuged in standard double sector cells at 50,000 r.p.m. and at 20°C. From the moving 
boundary, the parameters sedimentation (s) and diffusion (D) coefficients were 
calculated using the program LAMM29. Together with the partial specific volumes, 
the molecular masses were determined via the Svedberg equation and correspond-
ed in all cases to the expected values for the monomeric peptides. Therefore, as an 
estimate for the gross conformation, the frictional ratio (f/f0) was calculated.
f f
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with u, the specific volume of the macromolecule and ρ, the density of the liquid. 
(f/f0) is influenced by the two unknown variables shape and hydration. Assuming 
an average hydration of about 0.3 g bound water per g peptide, a hydration- 
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in which w is the portion of bound water. Division of f/f0 by the factor (f/f0)hy  
yields a shape-dependent frictional ratio (f/f0)shape, that permits the rough  
estimation of the molecular dimensions. With the knowledge of the molecular  
mass M, the dry volume (V) can be calculated according to equation 3, with the 
Avogadro number NA: 
V M N = ( )/ •u A
The dry volumes of the peptides were calculated based on the equation 4 and 5 for 
the description of sphere-like molecules 
V r =1 33 3 . p
with the particle radius corresponding to 
r
V
= 



0 75 1 3 . /
p
Equation 6 was used for rod-shaped molecules assuming a prolate ellipsoid of revo-
lution with the half-axis a and b (a > b). In case of the cyclic TAT, an oblate ellipsoid  
of revolution with the half-axis a and b (b > a) was assumed and calculated  
according to 
V ab =1 33 2 . p
a/b ratios derived from the Oncley-diagram30 yielded the dry volumes of the 
peptides.
Molecular dynamics simulations. For each of the five simulated peptides TAT, 
cyclic TAT, R10, PTD4, four molecular dynamics simulations over 10 ns were  
carried out at a temperature of 300 K using GROMACS 3.3.3 (ref. 31). The mole-
cules where modelled with the G43a1 force field and immersed in between 2,300 
(cyclic TAT) and 7,000 (Nemo-binding domain) water molecules (SPC model).  
Sodium and chloride counterions were added to achieve overall charge neutrality 
of the system and physiological ionic strength. To sample a diverse set of confor-
mations, the starting conditions were chosen differently in each simulation by 
using different random seeds and preparatory high-temperature simulations.  
Simulations were performed in NVT (number, volume and temperature kept 
constant) ensemble with periodic boundary conditions and Particle Mesh Ewald 
treatment of Coulomb interactions. Only the second half of each simulation has 
been evaluated for the histograms of radius of gyration and end–end distances  
to avoid biasing by starting conformations. These data are available as  
Supplementary Movies 2–5. 
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